Loss of LKB1 is Associated with Cisplatin Resistance in Oral Squamous Cell Carcinoma and Pharmacological Activation of the LKB1–AMPK Axis Attenuates the Resistant Phenotype
OncoTargets and Therapy · 2026-11 · Volume 19 · 1-15
DOI: 10.2147/ott.s645900 ↗Kurz gefasst
Fachartikel in der Zeitschrift OncoTargets and Therapy, 2026-11. Verfasst von Liru Zhang und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Zhang, L., Wang, Y., Zhang, N., Luo, X., & Zhang, J. (2026). Loss of LKB1 is Associated with Cisplatin Resistance in Oral Squamous Cell Carcinoma and Pharmacological Activation of the LKB1–AMPK Axis Attenuates the Resistant Phenotype. OncoTargets and Therapy, Volume 19, 1-15. https://doi.org/10.2147/ott.s645900
Vancouver
Zhang L, Wang Y, Zhang N, Luo X, Zhang J. Loss of LKB1 is Associated with Cisplatin Resistance in Oral Squamous Cell Carcinoma and Pharmacological Activation of the LKB1–AMPK Axis Attenuates the Resistant Phenotype. OncoTargets and Therapy. 2026;Volume 19:1-15. doi:10.2147/ott.s645900
BibTeX
@article{Zhang2026,
author = {Zhang, Liru and Wang, Yifan and Zhang, Nan and Luo, Xin and Zhang, Jing},
title = {Loss of LKB1 is Associated with Cisplatin Resistance in Oral Squamous Cell Carcinoma and Pharmacological Activation of the LKB1–AMPK Axis Attenuates the Resistant Phenotype},
journal = {OncoTargets and Therapy},
year = {2026},
volume = {Volume 19},
pages = {1--15},
doi = {10.2147/ott.s645900}
}
EUVIMED